Industry Council

History and Purpose

In 1998, to enhance the interaction between the functional GI disease patient community, the clinicians who care for them and the companies that provide the diagnostics, pharmaceuticals and other products used in their care, we formed the IFFGD Industry Council. The Council facilitates communication between IFFGD and the member companies and ensures that the voice of our patients is heard. The Industry Council helps fulfil IFFGD’s mission- to inform, assist, and support people affected by gastrointestinal disorders.

We invite participation from companies with a demonstrated interest in these disorders. Note that while we are grateful to our Industry Council supporters, we do not endorse any specific product or company.

Our Industry Council

Patron Level

Ironwood Pharmaceuticals

Salix Pharmaceuticals

Takeda Pharmaceutical Company Ltd.

Associate Level


Arena Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

Evoke Pharma, Inc.

Mauna Kea Technologies, Inc., Creators of Cellvizio

Neurogastrx, Inc.

Summit Therapeutics Inc.

Vanda Pharmaceuticals

See Industry Expanded Patient Assistance and Industry Research and Trials on COVID-19 here


Inquiries regarding participation in the IFFGD Industry Council should be directed to:

Ceciel T. Rooker, President
3015 Dunes West Blvd, Suite 512
Mount Pleasant, SC 29466

Phone: (414) 964-1799

Share this page
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Topics of this article
Was this article helpful?

IFFGD is a nonprofit education and research organization. Our mission is to inform, assist, and support people affected by gastrointestinal disorders.

Our original content is authored specifically for IFFGD readers, in response to your questions and concerns.

If you found this article helpful, please consider supporting IFFGD with a small tax-deductible donation.

Related Information
Personal Stories
Skip to content